about
Distribution of hepatitis B virus genotype and cancer predicting precore and basal core promoter mutations.Multiresistant Elizabethkingia meningoseptica infections in tertiary care.Correlation of CD4+ T cell Count with Total Lymphocyte Count, Haemoglobin and Erythrocyte Sedimentation Rate Levels in Human Immunodeficiency Virus Type-1 DiseasePrevalence of occult hepatitis B amongst Indian human immunodeficiency virus type 1 infected individuals-a pilot study.Seroprevalence of human parvovirus B19 in healthy blood donors.Prevalence of drug resistance in human immunodeficiency virus type 1-infected treatment-naive children in Pune, IndiaEmergence of drug resistance in human immunodeficiency virus type 1 infected patients from pune, India, at the end of 12 months of first line antiretroviral therapy initiation.In vitro vancomycin susceptibility amongst methicillin resistant Staphylococcus aureus.Heterogeneous vancomycin-intermediate among methicillin resistant Staphylococcus aureusAnti-HIV-1 antibody detection in urine.Outbreak of Pneumocystis jirovecii pneumonia in renal transplant recipients on prophylaxis: our observation and experience.Assessment of non-invasive models for liver fibrosis in chronic hepatitis B virus related liver disease patients in resource limited settings.Human immunodeficiency virus type 1 gp 41 mutations in proviral DNA among antiretroviral treatment-naive individuals from India.Profile of primary resistance in HIV-1-infected treatment-naive individuals from Western India.Evaluations of an in-house drug resistance method for HIV-1 drug resistance using ViroSeq™ 2.0 genotyping system as a gold standard.High prevalence of human immunodeficiency virus type 1 drug resistance mutations in antiretroviral treatment-experienced patients from Pune, India.Human immunodeficiency virus type 1 drug resistance mutations in peripheral blood mononuclear cell proviral DNA among antiretroviral treatment-naive and treatment-experienced patients from Pune, India.Periodontal pathogens in atheromatous plaque.HIV drug resistance following a decade of the free antiretroviral therapy programme in India: A review.Emergence of NNRTI Drug Resistance Mutations after Single-Dose Nevirapine Exposure in HIV Type 1 Subtype C-Infected Infants in IndiaFamilial Aggregation of Autoimmune Thyroiditis in First-Degree Relatives of Patients with Juvenile Autoimmune Thyroid DiseaseBenign Cervical Thymoma Masquerading as a Malignant Thyroid Nodule
P50
Q35947071-D434A89A-6B48-46A5-8E3E-E876540C9407Q35947111-CB4DE31A-794E-4125-8B50-8E4FCB8D2DD4Q37037165-61934959-B920-4EA4-AA42-8B5B1C6B8283Q37390442-90A44FBD-974C-42DF-87D8-F180FA0F0028Q37391153-104A7A80-2D4E-42A3-BBCD-BDB5596A9003Q37610659-D931D3DD-5CF6-4674-A17B-05416E8C5749Q37730759-CFA0450B-84BC-4971-836D-E3D7855E17A6Q41672254-EADF0E69-6750-45F2-9E2D-906AF7D18562Q41843806-7AF805B6-F661-420F-A170-62B4C9950DE7Q42015625-84D49CA2-F746-4AA4-B48A-316D3BC855D8Q42206832-DD974724-32F1-41F8-A2DA-B3F7F130273AQ42260338-8EB6AE64-9CF8-468F-94BC-5A02BE659EC9Q44226462-66155D01-D488-4179-993B-B65834671FE1Q44319594-F91153E0-4E57-45A3-8409-840062CBFF09Q44483809-B995F822-501E-4A6A-8D7F-2802354AD0ECQ45399518-F4B02A22-BCA7-4117-A437-4E0CD897E2FCQ45403939-7D61C48A-8E62-44DF-9DDE-97E43C7A58B5Q46877290-207B1633-A79E-4C41-A68D-021DBC38B5BDQ47583084-2330C1B5-EF16-41DB-96F9-BD88D105F536Q61906843-87024E5A-0ACE-4B22-99E4-6160ACE869DFQ61906853-1742AFB4-5F63-4274-9156-0222D19AD04AQ61906857-1E10778B-B5F3-439A-AE7F-B567F3DDFE66
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sourav Sen
@ast
Sourav Sen
@en
Sourav Sen
@es
Sourav Sen
@nl
Sourav Sen
@sl
সৌরভ সেন
@bn
type
label
Sourav Sen
@ast
Sourav Sen
@en
Sourav Sen
@es
Sourav Sen
@nl
Sourav Sen
@sl
সৌরভ সেন
@bn
prefLabel
Sourav Sen
@ast
Sourav Sen
@en
Sourav Sen
@es
Sourav Sen
@nl
Sourav Sen
@sl
সৌরভ সেন
@bn
P106
P1153
14055065200
P21
P31
P496
0000-0001-9117-2235
P569
2000-01-01T00:00:00Z